Alicanto Drugs Private Limited, a active private limited company, was established on 25 March 2019 in Panchkula, Haryana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U36995HR2019PTC079260. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.25 M.
Its leadership includes Atin Arora (Director), Naresh Arora (Director). It holds ₹1.01 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No 159 Industrial Area Phase 2, Panchkula, Haryana, 134113.
U36995HR2019PTC079260
079260
25 March 2019
₹1.00 M
₹0.25 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Alicanto Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Atin Arora | Director | 25 Mar 2019 | Current |
| Naresh Arora | Director | 25 Mar 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Alicanto Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 48.65% increase. The company also saw a substantial improvement in profitability, with a 218.1% increase in profit. The company's net worth Soared by an impressive increase of 182.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Alicanto Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,007,998.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jun 2022 | Hdfc Bank Limited | ₹1.01 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Alicanto Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Alicanto Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alicanto Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Alicanto Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Alicanto Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 1.01 M with Charge ID 100712475 was registered on 14 Jun 2022. was completed.
Progress on Atin Arora was appointed as a Director was appointed as a Director on 25 Mar 2019 & has been associated with this company since 6 years 9 months . was documented.
Progress on Naresh Arora was appointed as a Director was appointed as a Director on 25 Mar 2019 & has been associated with this company since 6 years 9 months . was documented.
The activity Alicanto Drugs Private Limited was registered on 25 Mar 2019 with Roc Delhi & aged 6 years 9 months as per MCA records. was completed.
The CIN of Alicanto Drugs Private Limited is U36995HR2019PTC079260.
Alicanto Drugs Private Limited is headquartered at Plot No 159 Industrial Area Phase 2, Panchkula, Haryana, 134113.
Alicanto Drugs Private Limited was incorporated on 25 March 2019.
The current directors of Alicanto Drugs Private Limited are
The primary industry of Alicanto Drugs Private Limited is Trade.
Alicanto Drugs Private Limited is unlisted.
The authorized capital of Alicanto Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹0.25 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX